37. Generalised pustular psoriasis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 93 / Drugs : 50 - (DrugBank : 21) / Drug target genes : 21 - Drug target pathways : 99
Generalised pustular psoriasis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 37 | Generalised pustular psoriasis | - |
| 49 | Systemic lupus erythematosus | 11.743 |
| 13 | Multiple sclerosis | 10.021 |
| 97 | Ulcerative colitis | 7.603 |
| 46 | Malignant rheumatoid arthritis | 6.344 |
| 53 | Sjogren syndrome | 4.860 |
| 65 | Primary immunodeficiency | 4.545 |
| 41 | Giant cell arteritis | 4.364 |
| 96 | Crohn disease | 4.315 |
| 160 | Congenital ichthyosis | 4.219 |
| 56 | Behcet disease | 3.335 |
| 50 | Dermatomyositis | 3.114 |
| 84 | Sarcoidosis | 2.838 |
| 162 | Pemphigoid | 2.564 |
| 269 | Pyogenic arthritis | 2.500 |
| 271 | Ankylosing spondylitis | 2.415 |
| 202 | Smith-Magenis syndrome | 2.362 |
| 75 | Cushing disease | 2.206 |
| 107 | Juvenile idiopathic arthritis | 1.611 |
| 299 | Cystic fibrosis | 1.445 |
| 2 | Amyotrophic lateral sclerosis | 1.359 |
| 40 | Takayasu arteritis | 1.312 |
| 39 | Toxic epidermal necrolysis | 1.145 |
| 15 | Inclusion body myositis | 1.145 |
| 106 | Cryopyrin-associated periodic syndrome | 1.100 |
| 90 | Retinitis pigmentosa | 1.061 |
| 36 | Epidermolysis bullosa | 1.061 |